Literature DB >> 17027863

"My son is still walking": stages of receptivity to discussions of advance care planning among parents of sons with Duchenne muscular dystrophy.

Lori Hamby Erby1, Cynda Rushton, Gail Geller.   

Abstract

Duchenne muscular dystrophy is an inherited progressive neuromuscular disease that generally results in death by early adulthood. Because of its life-threatening nature, discussions of advance care planning are extremely relevant to families with affected children and adolescents. Seventeen parents of sons with Duchenne muscular dystrophy were interviewed about their attitudes, experiences, and the nature of their discussions about these topics. Parents showed a lack of familiarity with and experience communicating about advance care planning. They also discussed opportunities for communication that centered on transitional life events. Parents appeared to vacillate between hope for future treatments, avoidance of emotionally difficult aspects of the disease, and presence with the fullness of life's experiences. These data suggest a model for future research in which windows of opportunity for discussion may exist as sons are approaching significant transitional milestones and parents are able to see the world through a lens of "presence."

Entities:  

Mesh:

Year:  2006        PMID: 17027863     DOI: 10.1016/j.spen.2006.06.009

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  9 in total

1.  Advance care planning in adults with cystic fibrosis.

Authors:  Gregory S Sawicki; Edward J Dill; Daniel Asher; Deborah E Sellers; Walter M Robinson
Journal:  J Palliat Med       Date:  2008-10       Impact factor: 2.947

2.  Mothers' psychological adaptation to Duchenne/Becker muscular dystrophy.

Authors:  Holly L Peay; Bettina Meiser; Kathleen Kinnett; Pat Furlong; Kathryn Porter; Aad Tibben
Journal:  Eur J Hum Genet       Date:  2015-08-26       Impact factor: 4.246

3.  Communication regarding breathing support options for youth with Duchenne muscular dystrophy.

Authors:  Eric Ferguson; Marilyn Wright; Teresa Carter; Cindy Van Halderen; Renata Vaughan; Margaret Otter
Journal:  Paediatr Child Health       Date:  2011-08       Impact factor: 2.253

4.  Palliative Care in Duchenne Muscular Dystrophy: A Study on Parents' Understanding.

Authors:  Arun Sadasivan; Manjusha G Warrier; Kiran Polavarapu; Veeramani Preethish-Kumar; Meera G Nair; M S Keerthipriya; Seena Vengalil; John Vijay Sagar; Thomas Kishore; Atchayaram Nalini; Priya Treesa Thomas
Journal:  Indian J Palliat Care       Date:  2021-02-17

5.  "Suddenly we have hope that there is a future": two families' narratives when a child with spinal muscular atrophy receives a new drug.

Authors:  Elin Hjorth; Malin Lövgren; Ulrika Kreicbergs; Thomas Sejersen; Eric Asaba
Journal:  Int J Qual Stud Health Well-being       Date:  2021-12

6.  Pediatric advance care planning from the perspective of health care professionals: a qualitative interview study.

Authors:  Julia D Lotz; Ralf J Jox; Gian Domenico Borasio; Monika Führer
Journal:  Palliat Med       Date:  2014-11-11       Impact factor: 4.762

7.  Factors associated with health professionals decision to initiate paediatric advance care planning: A systematic integrative review.

Authors:  Karen Carr; Felicity Hasson; Sonja McIlfatrick; Julia Downing
Journal:  Palliat Med       Date:  2020-12-29       Impact factor: 4.762

8.  The experiences of patients with Duchenne muscular dystrophy in facing and learning about their clinical conditions.

Authors:  Haruo Fujino; Yuko Iwata; Toshio Saito; Tsuyoshi Matsumura; Harutoshi Fujimura; Osamu Imura
Journal:  Int J Qual Stud Health Well-being       Date:  2016-10-05

9.  Keeping all options open: Parents' approaches to advance care planning.

Authors:  Emma Beecham; Linda Oostendorp; Joanna Crocker; Paula Kelly; Andrew Dinsdale; June Hemsley; Jessica Russell; Louise Jones; Myra Bluebond-Langner
Journal:  Health Expect       Date:  2016-09-26       Impact factor: 3.377

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.